| 中文摘要 | 第6-10页 |
| Abstract | 第10-14页 |
| Chapter 1 Background | 第18-24页 |
| Chapter 2 Review | 第24-34页 |
| Chapter 3 Materials and Methods | 第34-40页 |
| 3.1 Study participants and location | 第34页 |
| 3.2 Ethical statement | 第34页 |
| 3.3 Inclusion and exclusion criteria | 第34页 |
| 3.4 Clinical examination | 第34-35页 |
| 3.5 Reagents | 第35-36页 |
| 3.6 Main instruments and equipment | 第36页 |
| 3.7 Immuno-histochemical staining method | 第36-37页 |
| 3.8 Positive result judgment: | 第37页 |
| 3.9 WHO Grading | 第37-38页 |
| 3.10 ECOG score | 第38页 |
| 3.11 Statistical analysis | 第38-40页 |
| Chapter 4 Results | 第40-52页 |
| 4.1 Patients' demographic information (Gender and Age) | 第40页 |
| 4.2 Location of Meningioma | 第40-41页 |
| 4.3 Distribution of study subjects by tumor size | 第41页 |
| 4.4 Distribution of patients by Simpson's grade | 第41-42页 |
| 4.5 Distribution of patients by the WHO 2007 criteria | 第42页 |
| 4.6 Brain invasion of the meningioma | 第42-43页 |
| 4.7 Presence or absence of Tumor recurrence | 第43-44页 |
| 4.9 Analysis of the Expression of EMA ,CD34, KI-67 and Progesteronereceptor (PR)in meningioma's | 第44-46页 |
| 4.10 Differences characteristics based on WHO grades | 第46-48页 |
| 4.11 Differences characteristics based on the presence of tumor braininvasion | 第48-50页 |
| 4.12 Differences characteristics between subjects with and withoutrecurrent meningioma | 第50-52页 |
| Chapter 5 Discussion | 第52-55页 |
| Chapter 6 Conclusions | 第55-56页 |
| References | 第56-60页 |
| Author's brief introduction | 第60-61页 |
| ACKNOWLEDGEMENTS | 第61页 |
